Skip to content

Clinical trials

Phase 3 Crohn Disease trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Crohn Disease Phase: Phase 3 Country / region: China Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20177
20185
20191
20202
20222
20234
20243
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting11
Active, not recruiting7
Completed7
Terminated2
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie10
Janssen Research & Development, LLC4
Takeda4
Celgene3
Eli Lilly and Company2
Sanofi2
Sixth Affiliated Hospital, Sun Yat-sen University2
Jiangsu Topcel-KH Pharmaceutical Co., Ltd.1
Merck Sharp & Dohme LLC1
Xijing Hospital of Digestive Diseases1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Crohn Disease30
Colitis, Ulcerative2
Arthritis, Juvenile1
Arthritis, Psoriatic1
Oral Ulcer1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.